UCSF Children's Medical Center names bravekids.org resource center
University of California San Francisco
Displaying 16351 - 16380 of 16507
-
-
An assessment of yourself as rich and powerful may keep you healthy, according to UCSF study
Scientists have known for decades that poverty leads to higher rates of illness and mortality. More recent research led by UCSF faculty has shown that these effects don't end at the poverty line. In fact, health improves at each step of the social ladder.
-
Protein stimulates key link between nerve cells, suggesting possible target for mental retardation a
UCSF researchers have exposed a single protein that can stimulate the maturation of the synapses, or junctures, through which nerve cells communicate a key signal to one another.
-
Physicians need better training in end-of-life care, according to UCSF editors of new JAMA series
Too frequently, clinicians feel lost and out of place caring for dying patients. They often fear that recognizing the imminence of death may minimize a patient's hope...
-
Botox treatment for wrinkles may also relieve migraines
A treatment commonly used by dermatologists to get rid of facial wrinkles may also help migraine sufferers, a UCSF researcher has reported.
-
UCSF study shows that drug administered during heart procedures preserves blood flow into the heart
A drug commonly used during invasive heart procedures not only helps maintain blood flow through the large blood vessels that have been enlarged during the procedure, but also preserves blood flow through the smaller blood vessels downstream that may become blocked by debris.
-
SFVAMC/UCSF Researchers Develop Lead for a New Alzheimer's Disease Drug
In findings that could lead to a new Alzheimer's disease drug, researchers at SFVAMC and University of California, San Francisco have isolated a protein fragment that nurtures brain cells, an effect that could prevent loss of brain function caused by the disease.
-
Major cancer forum builds bridges of understanding--event addresses similarities between breast and
-
Report on dietary supplements containing ephedra makes urgent call for research to develop dose guid
A study undertaken for the Food and Drug Administration to assess the safety of popular dietary supplements containing ephedra concludes that these products can pose severe health risks and even kill some people...
-
UCSF epidemiologist George Rutherford selected to head National Advisory Council for VA research
-
University of California, San Francisco responds to inaccurate claims by company
-
UCSF-Harvard team publishes major HIV therapy study over objections of sponsor; compound shows no ef
Researchers led by University of California, San Francisco and Harvard School of Public Health are reporting the largest randomized trial among HIV-1 infected persons conducted during the 1990s.
-
Growing number of financial ties between academic researchers and private industry shows need for st
While private industry involvement in academic research continues to grow rapidly, universities struggle to prevent potential conflicts of interest without clear guidelines for defining or managing financial conflicts...
-
UCSF/VA researcher to be awarded presidental early career award for promising research on molecules
-
Commonly used herbal product lowers PSA level in men with advanced prostate cancer, UCSF study finds
A popular herbal supplement used by prostate cancer patients has been found to significantly reduce prostate specific antigen (PSA) levels -- a protein in the blood that often indicates prostate cancer...
-
UCSF researchers call for shift in HIV prevention priorities
HIV prevention resources are not allocated in the most cost-effective fashion say researchers at the UCSF Center for AIDS Prevention Studies (CAPS).
-
UCSF-led study offers insight into cancer development, resistance to therapy: finding focuses on Ras
UCSF-led scientists have determined that under certain conditions the Ras oncogene, a key culprit in many cancers, suppresses the function of the p53 tumor-suppressor gene...
-
UCSF team reveals how the most selective of all cell gatekeepers works -- a "three-faced" channel vi
A University of California, San Francisco biochemist and colleagues have revealed the atom-by-atom structure of an ancient and extremely discriminating kind of channel embedded in cell membranes, from bacteria to humans.
-
Four UCSF faculty scientists elected to Institute of Medicine
-
Group appointments can benefit busy doctors and chronically ill patients, according to UCSF research
-
UCSF Comprehensive Cancer Center Program triumphs with highly coveted grant to conquer prostate canc
-
Glide clinic to offer acupuncture, Reiki, Shiatsu and other complementary therapies to the underserv
-
UCSF researchers report interventions for victims of domestic violence
A recent study of San Francisco Bay Area physicians reports on successful intervention techniques for victims of domestic violence.
-
Scientists discover new molecule of the immune system; a chemokine that binds one of the HIV co-rece
A team of scientists at the University of California, San Francisco and Compugen, Ltd. has discovered a new molecule of the immune system -- a member of a family of proteins called chemokines which recruit the body's army of defensive immune cells to sites of invasion.
-
UCSF enrolling patients for trial testing immunotherapy treatment for cancer
-
UCSF Audiology Clinic offers world's first disposable hearing aids
-
UCSF finding suggests mechanism of experimental cancer drug, hinting at broader application for the
University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected...
-
CPR training for parents of high-risk neonates improves family adjustment at home
Cardiopulmonary (CPR) training can relieve stress for parents and improve survival outcomes for infants at high risk for cardiopulmonary arrest, a new study has found.
-
Scientists develop chemical switch for natural signaling molecules, opening new approach to biomedic
A team led by a University of California, San Francisco scientist has developed drug-like inhibitors to study vital signaling molecules essential for almost all cell activity.
-
Prominent immunologist and leader in diabetes research joins UCSF study
Jeffrey A. Bluestone, PhD, one of the world's leading experts on why the body's immune system rejects or tolerates transplanted tissue, has been appointed to a new professorship at the University of California, San Francisco devoted to diabetes research.